KAYLAN BURKETT: Open Payments
NPI 1972073013 · SUN CITY WEST, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 50 payments from 14 companies in 2025. Trend: 2023 $929 · 2024 $673 · 2025 $1,240
Food & beverage: $1,240
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $296 |
| GlaxoSmithKline, LLC. | 10 | $181 |
| Medtronic, Inc. | 2 | $171 |
| Boston Scientific Corporation | 1 | $135 |
| Lilly USA, LLC | 10 | $119 |
| Novo Nordisk Inc | 4 | $86 |
| PFIZER INC. | 4 | $70 |
| Abbott Laboratories | 2 | $43 |
| ABBVIE INC. | 2 | $36 |
| Exact Sciences Corporation | 2 | $27 |
Products named: FARXIGA, CLOSUREFAST, TRELEGY ELLIPTA, WATCHMAN FLX, JARDIANCE, Ozempic, MOUNJARO, Rybelsus.
Industry payments across AZ — which companies pay providers there.
